Applied DNA Sciences Inc (NAS:APDN)
$ 3.74 0.005 (0.13%) Market Cap: 3.23 Mil Enterprise Value: 986,000.00 PE Ratio: 0 PB Ratio: 0.61 GF Score: 50/100

Q4 2019 Applied DNA Sciences Inc Earnings Call Transcript

Dec 12, 2019 / 09:30PM GMT
Release Date Price: $85.2 (+2.16%)
Operator

Good afternoon, and welcome to the Applied DNA Sciences' Fourth Quarter and Fiscal Year-end 2019 Financial Results Conference Call. (Operator Instructions) Please note, this event is being recorded. I would now like to turn the conference over to Clay Shorrock, General Counsel. Please go ahead.

Clay Shorrock
Applied DNA Sciences, Inc. - General Counsel

Thank you, operator, and good afternoon, everyone, and thank you for joining us for our fiscal fourth quarter and full 2019 fiscal year results conference call. A copy of the company's earnings press release and accompanying PowerPoint presentation to this call are available for download under the Events and Presentations section to the investor page of the Applied DNA website. With me on today's call are Dr. James Hayward, Chairman, President and CEO; and Beth Jantzen, Chief Financial Officer.

As a reminder, please note that some of the information you will hear today during our discussion may consist of forward-looking statements, including, without limitation, those regarding gross margins, operating

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot